New hope for transplant survivors with rare lung disease?
NCT ID NCT03805477
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a drug called nintedanib in 20 people who developed bronchiolitis obliterans syndrome (a lung condition) after a stem cell transplant. Participants take the drug daily for 12 months on top of their usual anti-rejection medicines. The goal is to see if the drug is safe and can help slow lung function decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS SYNDROME (BOS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinic of Hematology, University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinic of Respiratory Medicine, University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
King Faisal Specialist Hospital & Research Centre
RECRUITINGRiyadh, 11471, Saudi Arabia
Contact
Conditions
Explore the condition pages connected to this study.